Blood Flow Mismatch in Pancreatic Cancers Wilmington NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Andrew Philip Brown, MD
(910) 763-1137
2800 Ashton Dr
Wilmington, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of London, Royal Free Hosp Sch Med (See 917-34)
Graduation Year: 1978

Data Provided by:
Arvil D Stephen, MD
(910) 772-7573
3151 S 17th St
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
William McNulty, MD
(910) 343-0447
1520 Physicians Dr
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Sc Sch Of Med, Columbia Sc 29208
Graduation Year: 1982

Data Provided by:
Birgit Arb, MD
(919) 763-5182
1515 Doctors Cir
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Pa State Univ Coll Of Med, Hershey Pa 17033
Graduation Year: 1991

Data Provided by:
Walter Henry Gajewski, MD
(910) 762-9093
2131 S 17th St
Wilmington, NC
Specialties
Oncology (Cancer), Gynecological Oncology, Obstetrics And Gynecology
Gender
Male
Education
Medical School: Med Univ Of Sc Coll Of Med, Charleston Sc 29425
Graduation Year: 1982
Hospital
Hospital: St Annes Hospital, Fall River, Ma; Rhode Island Hospital, Providence, Ri; Women & Infants Hospital Of R, Providence, Ri
Group Practice: Anesthesia Associates Of New London Pc

Data Provided by:
Peter Ungaro, MD
(910) 342-3001
109 Darley Ln
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
John William Anagnost, MD
(910) 343-0447
1515 Doctors Cir
Wilmington, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Jefferson Med Coll-Thos Jefferson Univ, Philadelphia Pa 19107
Graduation Year: 1978
Hospital
Hospital: New Hanover Reg Med Ctr, Wilmington, Nc; Cape Fear Mem Hosp, Wilmington, Nc
Group Practice: Hanover Medical Specialists

Data Provided by:
Peter C Mancusi-Ungaro
(910) 343-7597
2131 S 17th St
Wilmington, NC
Specialty
Hematology / Oncology

Data Provided by:
William Mc Nulty, MD
(910) 763-5182
1515 Doctors Cir
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Sc Sch Of Med, Columbia Sc 29208
Graduation Year: 1982

Data Provided by:
Elizabeth Harrer Yoffe, MD
7221 Gray Gables
Wilmington, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1977

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com